Nxera Pharma UK Limited

Active06267989 Private limited company
Incorporated
4 June 2007 (19 years)
Previously known as
Heptares Therapeutics Limited (until 2 April 2024)
This list may be incomplete. See all names on Companies House
Industry
Research and experimental development on biotechnology (72110)
Directors
Mariko Nakafuji
Candelle Wai-Yee Chong
Owned by
Nxera Pharma Co., Ltd.
Accounts type
Full
Region
East of England
Address
Granta Park
Great Abington
Cambridge
CB21 6DG

Filing status

Accounts due
30 September 2027
Last accounts
31 December 2025
Conf. stmt due
13 June 2027
Last conf. stmt
30 May 2026

Charges

Total
1
Outstanding
0
Part satisfied
0
Satisfied
1

Officers 5 active

Officer details are public data from the Companies House register.

Director · Appointed 21 October 2025
Also at Serenza Therapeutics Ltd
British
Born December 1971 (54)
Nakafuji, Mariko
Director · Appointed 1 April 2025
Japanese
Born December 1985 (40)
Chong, Candelle Wai-Yee
Director · Appointed 30 March 2023
British
Born October 1989 (37)
Nakafuji, Mariko
Secretary · Appointed 16 July 2021
Director · Appointed 21 January 2019
Also at Beechwood Park (Chorleywood) Limited · more companies
British
Born May 1969 (57)
Officer history (23 former)
14 October 2026
Resigned Cargill, Christopher Robert as Director
21 October 2025
Appointed Foerch, Patrik, Dr as Director
30 September 2025
Resigned Barnes, Matthew Joseph as Director
1 April 2025
Appointed Nakafuji, Mariko as Director
30 March 2023
Appointed Chong, Candelle Wai-Yee as Director
24 March 2022
Resigned Weir, Malcolm, Dr as Director
24 March 2022
Appointed Barnes, Matthew Joseph as Director
24 March 2022
Resigned Tasker, Timothy Charles Gadsden, Dr as Director
16 July 2021
Appointed Nakafuji, Mariko as Secretary
16 July 2021
Resigned Brimblecombe, Andrew as Secretary
21 January 2019
Appointed Cargill, Christopher Robert as Director
21 January 2019
Appointed Brimblecombe, Andrew as Secretary
21 January 2019
Appointed Johnson, Kieran Roy Darren as Director
28 February 2018
Appointed Tasker, Timothy Charles Gadsden, Dr as Director
28 February 2018
Resigned Marshall, Fiona Hamilton, Dr as Director
21 July 2016
Resigned Bains, Peter James Jonathan as Director
21 July 2016
Resigned Doogan, Declan, Dr as Director
31 May 2016
Resigned Pande, Atul, Dr as Director
31 May 2016
20 February 2015
Appointed Bains, Peter James Jonathan as Director
20 February 2015
Appointed Doogan, Declan, Dr as Director
20 February 2015
Resigned Steinmetz, Ludwig Michael, Dr as Director
20 February 2015
Appointed Marshall, Fiona Hamilton, Dr as Director
20 February 2015
Resigned Bednarski, Eric, Dr as Director
20 February 2015
Resigned Berriman, John Edward as Director
20 February 2015
Resigned Koenig, Anja, Dr as Director
1 December 2014
Appointed Pande, Atul, Dr as Director
12 June 2014
12 June 2014
Resigned Henderson, Richard, Dr as Director
3 April 2013
Resigned Perlmutter, Roger M, Dr as Director
22 October 2012
Appointed Perlmutter, Roger M, Dr as Director
27 March 2012
Appointed Bednarski, Eric, Dr as Director
27 March 2012
Resigned Murphy, Martin Patrick, Dr as Director
22 May 2009
Resigned Resolve Cambridge Limited as Corporate Secretary
17 February 2009
Appointed Steinmetz, Ludwig Michael, Dr as Director
17 February 2009
Appointed Koenig, Anja, Dr as Director
17 February 2009
Resigned Marshall, Fiona Hamilton as Director
17 February 2009
Resigned Casdagli, Thomas Theodore as Director
14 August 2007
Appointed Marshall, Fiona Hamilton as Director
14 August 2007
Resigned Casdagli, Thomas Theodore as Secretary
14 August 2007
Appointed Resolve Cambridge Limited as Corporate Secretary
20 July 2007
Appointed Henderson, Richard, Dr as Director
20 July 2007
Appointed Berriman, John Edward as Director
5 July 2007
Appointed Murphy, Martin Patrick, Dr as Director
5 July 2007
Appointed Casdagli, Thomas Theodore as Director
5 July 2007
Appointed Weir, Malcolm, Dr as Director
5 July 2007
Appointed Casdagli, Thomas Theodore as Secretary
5 July 2007
Resigned Ingleby Nominees Limited as Corporate Secretary
5 July 2007
Resigned Ingleby Holdings Limited as Corporate Director
4 June 2007
Appointed Ingleby Nominees Limited as Corporate Secretary
4 June 2007
Appointed Ingleby Holdings Limited as Corporate Director

Ownership 1 active

People and entities with significant control, from the Companies House PSC register

Nxera Pharma Co., Ltd.
Corporate entity · Notified 6 April 2016
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Corporate
Reg. no. 0100-01-021288

Holdings 1

Companies where Nxera Pharma UK Limited is registered as a person with significant control

Owns 25–50% of shares
Active
Former controllers (3)
31 December 2018
Ceased Peter Jonathan Bains — Right to appoint and remove directors (as a firm)
31 December 2018
Ceased Malcolm Weir — Right to appoint and remove directors (as a firm)
28 February 2018
Ceased Fiona Hamilton Marshall — Right to appoint and remove directors (as a firm)

Filings

Recent filings only. See the full history on Companies House

DateDescriptionMade Up ToPagesPDF
29 October 2026Termination of appointment of a director
25 July 2026Full accounts31 December 2025
3 June 2026Withdrawal of a person with significant control statement
3 June 2026Notification of a person with significant control
2 June 2026Confirmation statement with no updates30 May 2026
Show all recent filings

Other companies in this industry

Liverpool
Caerphilly
London
Oxford
Oxford
Sandwich

By trade and location

New companies in Cambridge →

Explore the largest companies

Largest companies in Cambridge, UK →

Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →

← Back to companies Official record on Companies House ↗

Already have an account?

Create your account

Save searches and get the weekly email of new matches.

First name is required.
Last name is required.
Enter an email address like name@example.com.
Must be at least 8 characters. Password must be at least 8 characters.

Already have an account?